Detalhe da pesquisa
1.
Pitavastatin to Prevent Cardiovascular Disease in HIV Infection.
N Engl J Med
; 389(8): 687-699, 2023 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37486775
2.
Pericoronary Adipose Tissue Density, Inflammation, and Subclinical Coronary Artery Disease Among People With HIV in the REPRIEVE Cohort.
Clin Infect Dis
; 77(12): 1676-1686, 2023 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37439633
3.
Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV: Mechanistic Substudy of the REPRIEVE Randomized Clinical Trial.
JAMA Cardiol
; 9(4): 323-334, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38381407
4.
Hepatic steatosis and nonalcoholic fatty liver disease are common and associated with cardiometabolic risk in a primary prevention cohort of people with HIV.
AIDS
; 37(14): 2149-2159, 2023 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37503623
5.
The importance of methods for site performance evaluation in REPRIEVE, a longitudinal, global, multicenter trial.
Contemp Clin Trials
; 124: 107035, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36462699